Vanguard Global Advisers »

Cabaletta Bio shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $96k 36k 2.69

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Cabaletta Bio

T. Rowe Price Investment Management
Bain Capital Life Sciences Investors
Jennison Associates
Adage Capital Partners GP
Millennium Management
Cormorant Asset Management
Vanguard Group
Vanguard Capital Management
Two Sigma Investments
BlackRock
Superstring Capital Management
Renaissance Technologies
Morgan Stanley
Opaleye Management
Woodline Partners

View all funds holding Cabaletta Bio